Mamluk Roni 4

Accession 0001209191-21-050039

CIK 0001339469other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 6:00 PM ET

Size

22.2 KB

Accession

0001209191-21-050039

Form 4

Period: 2021-08-05

Chief Development Officer

Transactions

Disposition to Issuer
Stock Option (Right to Buy)
2021-08-05−13,000→ 0 total
Exercise: $5.81→ Common Stock (13,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-08-05−225,689→ 0 total
Exercise: $3.29→ Common Stock (225,689 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-08-05−213,345→ 0 total
Exercise: $5.57→ Common Stock (213,345 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-08-05−13,000→ 0 total
Exercise: $7.98→ Common Stock (13,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-08-05−40,000→ 0 total
Exercise: $9.93→ Common Stock (40,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-08-05−42,019→ 0 total
Exercise: $1.85→ Common Stock (42,019 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-08-05−26,000→ 0 total
Exercise: $1.35→ Common Stock (26,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-08-05−13,000→ 0 total
Exercise: $1.45→ Common Stock (13,000 underlying)

Footnotes (2)

[F1]This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated as of May 4, 2021, by and among Chiasma, Inc. (the "Company), Amryt Pharma plc ("Parent"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent ("Merger Sub") pursuant to which Merger Sub merged with and into the Company (the "Merger") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the "Effective Time").
[F2]At the Effective Time, each option to purchase Shares (each a "Company Option") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an "Assumed Stock Option") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio.

Documents

1 file

CHIASMA, INC

CIK 0001339469

Entity typeother